Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Personalised Therapeutic Approach for Cancer Patients With Resting Hypermetabolism

NCT05281354 is registered in ClinicalTrials.gov with Centre Hospitalier le Mans as lead sponsor.

NCT NCT05281354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05281354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Personalised Therapeutic Approach for Cancer Patients With Resting Hypermetabolism
Lead sponsor
Centre Hospitalier le Mans
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2022
Completion date
August 1, 2023
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer